Skip to main content
Fig. 2 | Clinical Proteomics

Fig. 2

From: Rational selection of a biomarker panel targeting unmet clinical needs in kidney injury

Fig. 2

Paradigm shift from current practice to desirable clinical practice by targeting suboptimal detection of kidney injury using a kidney injury biomarker panel. Test purposes and test roles of individual panel proteins in the clinical care pathway are driven by the identified unmet clinical needs. Early optimised treatment may prevent conversion to irreversible structural kidney damage and would improve patient outcome

Back to article page

Clinical Proteomics

ISSN: 1559-0275